阿片类药物使用与外周动脉疾病的关联
本研究基于Truven Health MarketScan数据库2007至2015年数据,纳入178,880例外周动脉疾病(PAD)患者,评估PAD与高风险阿片类药物使用的关系及PAD治疗对阿片使用的影响。结果显示平均24.7%患者在某一年份达到高阿片使用标准,新诊断PAD和重症肢体缺血(CLI)均增加高阿片使用,PAD治疗亦使高阿片使用者比例从25.8%升至29.6%。
要点
- PAD患者中近四分之一达到高阿片使用标准,需加强阿片管理意识。
- 新诊断PAD和CLI均与高阿片使用风险增加相关。
- PAD相关治疗后排除了围手术期处方,高阿片使用者比例仍显著上升。
核心结论
- PAD患者高阿片使用风险增加,近四分之一符合标准。
- CLI和PAD治疗进一步增加高阿片使用。
研究设计与样本
- 回顾性队列研究,使用Truven Health MarketScan数据库2007至2015年数据。
- 纳入178,880例PAD患者,35%有CLI,平均随访5.3±2.1年。
主要发现
- 任一日历年平均24.7%患者符合高阿片使用标准,2010年后小幅显著下降(P < .01)。
- 高阿片使用年份年均填写5.9±5.5张处方。
- 新诊断PAD后高阿片使用从21.7%升至27.3%(P < .001)。
- CLI诊断后高阿片使用从25.4%升至34.5%(P < .001)。
- 多变量分析中背痛(OR 1.89,95%CI 1.84-1.93,P < .001)和非法药物使用(OR 1.87,95%CI 1.72-2.03,P < .001)为最强预测因素,CLI(OR 1.61,95%CI 1.57-1.64,P < .001)亦相关。
关键数值与推荐
- 高阿片使用定义为1年内两次或以上阿片处方。
- PAD定义为相隔≥2个月的两个以上ICD-9诊断代码且连续参保至少2年。
- CLI定义为静息痛、溃疡或坏疽。
- 43,443例(24.3%)患者接受80,816次PAD相关手术,排除围手术期处方(占所有阿片处方4.9%)后,高阿片使用者比例从治疗前25.8%升至治疗后29.6%(P < .001)。
临床怎么用
- 血管外科医生应意识到PAD患者高阿片使用风险,主动进行阿片管理。
- 对CLI患者和接受PAD治疗的患者应加强阿片使用监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prescription opioids account for 40% of all U.S. opioid overdose deaths, and national efforts have intensified to reduce opioid prescriptions. Little is known about the relationship between peripheral artery disease (PAD) and high-risk opioid use. The objectives of this study were to evaluate this relationship and to assess the impact of PAD treatment on opiate use. METHODS: In this retrospective cohort study, the Truven Health MarketScan database (Truven Health Analytics, Ann Arbor, Mich), a deidentified national private insurance claims database, was queried to identify patients with PAD (two or more International Classification of Diseases, Ninth Revision diagnosis codes of PAD ≥2 months apart, with at least 2 years of continuous enrollment) from 2007 to 2015. Critical limb ischemia (CLI) was defined as the presence of rest pain, ulcers, or gangrene. The primary outcome was high opioid use, defined as two or more opioid prescriptions within a 1-year period. Multivariable analysis was used to determine risk factors for high opioid use. RESULTS: A total of 178,880 patients met the inclusion criteria, 35% of whom had CLI. Mean ± standard deviation follow-up time was 5.3 ± 2.1 years. An average of 24.7% of patients met the high opioid use criteria in any given calendar year, with a small but significant decline in high opioid use after 2010 (P < .01). During years of high opioid use, 5.9 ± 5.5 yearly prescriptions were filled. A new diagnosis of PAD increased high opioid use (21.7% before diagnosis vs 27.3% after diagnosis; P < .001). A diagnosis of CLI was also associated with increased high opioid use (25.4% before diagnosis vs 34.5% after diagnosis; P < .001). Multivariable analysis identified back pain (odds ratio [OR], 1.89; 95% confidence interval [CI], 1.84-1.93; P < .001) and illicit drug use (OR, 1.87; 95% CI, 1.72-2.03; P < .001) as the highest predictors of high opioid use. A diagnosis of CLI was also associated with higher risk (OR, 1.61; 95% CI, 1.57-1.64; P < .001). A total of 43,443 PAD patients (24.3%) underwent 80,816 PAD-related procedures. After exclusion of periprocedural opioid prescriptions (4.9% of all opioid prescriptions), the yearly percentage of high opioid users increased from 25.8% before treatment to 29.6% after treatment (P < .001). CONCLUSIONS: Patients with PAD are at increased risk for high opioid use, with nearly one-quarter meeting described criteria. CLI and treatment for PAD additionally increase high opioid use. In addition to heightened awareness and active opioid management, our findings warrant further investigation into underlying causes and deterrents of high-risk opioid use.
引用
- Itoga NK, Sceats LA, Stern JR, et al. Association of opioid use and peripheral artery disease. J Vasc Surg. 2019. PMID: 30922747. doi:10.1016/j.jvs.2018.12.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。